A big part of staying healthy is taking care of your immune system. Now is a great time to work on strengthening your immune system before the cold and flu season arrives. But how exactly can you ...

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, ...

With the crisp chill in the air signaling the arrival of cold season and whatever else is floating in the air, it’s time to focus on strengthening our immune systems and enhancing our overall ...

Tivozanib Plus Nivolumab vs Tivozanib Monotherapy in Patients with Renal Cell Carcinoma Following an Immune Checkpoint ...

Injecting regulatory T cells or Tregs, which control the body’s immune responses, directly into damaged bone, muscle and skin ...

Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients ...

Bioengineer Ankur Singh works to create functional models of the human immune system in the lab. (Credit: Ankur Singh) ...

Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients ...

Merck gets US FDA approval for Keytruda plus pemetrexed & platinum chemotherapy to treat unresectable advanced or metastatic MPM: Rahway, New Jersey Thursday, September 19, 2024, ...

The addition of nivolumab (Opdivo) to tivozanib (Fotivda) compared with tivozanib alone failed to improve outcomes as second- ...

ORRs of 54.8% and 50.0% achieved in locally advanced and metastatic cSCC, with median follow-up durations of 24.1 and 29.3 months, respectively. Results demonstrate a deepening of response over time, ...

Study Meets Overall Response Rate Primary Endpoint, Encouraging Secondary Endpoint Progression-Free Survival Data in Squamous Cell Carcinoma ...